AAAAAA

   
Results: 1-25 | 26-45 |
Results: 26-45/45
CIRCULATING ACTIVATED PROTEIN-C (APC) LEVELS ARE PROPORTIONAL TO THE CONCENTRATION OF TOTAL PROTEIN-C
Authors: ESPANA F SANCHEZCUENCA J ESTELLES A GILABERT J AZNAR J
Citation: F. Espana et al., CIRCULATING ACTIVATED PROTEIN-C (APC) LEVELS ARE PROPORTIONAL TO THE CONCENTRATION OF TOTAL PROTEIN-C, Thrombosis and haemostasis, 73(6), 1995, pp. 938-938
THE EFFECT OF HORMONE-REPLACEMENT THERAPY ON THE FIBRINOLYTIC SYSTEM,COAGULATION INHIBITORS AND LIPOPROTEIN(A) IN POSTMENOPAUSAL STATUS
Authors: ESTELLES A GILABERT J CANO A ESPANA F BARRACHINA R GRANCHA S AZNAR J TORTAJADA M
Citation: A. Estelles et al., THE EFFECT OF HORMONE-REPLACEMENT THERAPY ON THE FIBRINOLYTIC SYSTEM,COAGULATION INHIBITORS AND LIPOPROTEIN(A) IN POSTMENOPAUSAL STATUS, Thrombosis and haemostasis, 73(6), 1995, pp. 1135-1135
FUNCTIONAL-CHARACTERIZATION OF A NEW FACTOR-XII VARIANT DENOTED AS FACTOR-XII VALENCIA
Authors: HOVINGA JK ESPANA F FURLAN M LAMMLE B
Citation: Jk. Hovinga et al., FUNCTIONAL-CHARACTERIZATION OF A NEW FACTOR-XII VARIANT DENOTED AS FACTOR-XII VALENCIA, Thrombosis and haemostasis, 73(6), 1995, pp. 1406-1406
FIBRINOLYTIC SYSTEM AND REPRODUCTIVE PROCESS WITH SPECIAL REFERENCE TO FIBRINOLYTIC FAILURE IN PREECLAMPSIA
Authors: GILABERT J ESTELLES A GRANCHA S ESPANA F AZNAR J
Citation: J. Gilabert et al., FIBRINOLYTIC SYSTEM AND REPRODUCTIVE PROCESS WITH SPECIAL REFERENCE TO FIBRINOLYTIC FAILURE IN PREECLAMPSIA, Human reproduction, 10, 1995, pp. 121-131
ACTIVATION OF THE PROTEIN-C PATHWAY IN ACUTE SEPSIS
Authors: ALCARAZ A ESPANA F SANCHEZCUENCA J ZUAZU I ESTELLES A AZNAR J VICENTE V
Citation: A. Alcaraz et al., ACTIVATION OF THE PROTEIN-C PATHWAY IN ACUTE SEPSIS, Thrombosis research, 79(1), 1995, pp. 83-93
COMPLEXES OF TISSUE KALLIKREIN WITH PROTEIN-C INHIBITOR IN HUMAN SEMEN AND URINE
Authors: ESPANA F FINK E SANCHEZCUENCA J GILABERT J ESTELLES A WITZGALL K
Citation: F. Espana et al., COMPLEXES OF TISSUE KALLIKREIN WITH PROTEIN-C INHIBITOR IN HUMAN SEMEN AND URINE, European journal of biochemistry, 234(2), 1995, pp. 641-649
THE EFFECT OF ESTROGEN REPLACEMENT THERAPY WITH OR WITHOUT PROGESTOGEN ON THE FIBRINOLYTIC SYSTEM AND COAGULATION INHIBITORS IN POSTMENOPAUSAL STATUS
Authors: GILABERT J ESTELLES A CANO A ESPANA F BARRACHINA R GRANCHA S AZNAR J TORTAJADA M
Citation: J. Gilabert et al., THE EFFECT OF ESTROGEN REPLACEMENT THERAPY WITH OR WITHOUT PROGESTOGEN ON THE FIBRINOLYTIC SYSTEM AND COAGULATION INHIBITORS IN POSTMENOPAUSAL STATUS, American journal of obstetrics and gynecology, 173(6), 1995, pp. 1849-1854
EVALUATION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN PLASMA AND AMNIOTIC-FLUID IN PREGNANCIES COMPLICATED WITH INTRAUTERINE FETAL GROWTH-RETARDATION
Authors: GILABERT J ESTELLES A AYUSO MJ ESPANA F CHIRIVELLA M GRANCHA S MICO JM AZNAR J
Citation: J. Gilabert et al., EVALUATION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN PLASMA AND AMNIOTIC-FLUID IN PREGNANCIES COMPLICATED WITH INTRAUTERINE FETAL GROWTH-RETARDATION, Gynecologic and obstetric investigation, 38(3), 1994, pp. 157-162
ALTERATIONS IN FIBRINOLYTIC AND PROTEIN-C PATHWAYS IN GYNECOLOGICAL SURGERY - LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS
Authors: ESTELLES A GILABERT J ESPANA F VILA J MARTINEZ M HENDL S AZNAR J
Citation: A. Estelles et al., ALTERATIONS IN FIBRINOLYTIC AND PROTEIN-C PATHWAYS IN GYNECOLOGICAL SURGERY - LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS, Haemostasis, 24(4), 1994, pp. 252-260
ALTERED EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PLACENTAS FROM PREGNANT-WOMEN WITH PREECLAMPSIA AND OR INTRAUTERINE PETAL GROWTH-RETARDATION/
Authors: ESTELLES A GILABERT J KEETON M EGUCHI Y AZNAR J GRANCHA S ESPANA F LOSKUTOFF DJ SCHLEEF RR
Citation: A. Estelles et al., ALTERED EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PLACENTAS FROM PREGNANT-WOMEN WITH PREECLAMPSIA AND OR INTRAUTERINE PETAL GROWTH-RETARDATION/, Blood, 84(1), 1994, pp. 143-150
EVIDENCE FOR THE REGULATION OF UROKINASE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS BY THE SERPIN, PROTEIN-C INHIBITOR, IN SEMEN AND BLOOD-PLASMA
Authors: ESPANA F ESTELLES A FERNANDEZ PJ GILABERT J SANCHEZCUENCA J GRIFFIN JH
Citation: F. Espana et al., EVIDENCE FOR THE REGULATION OF UROKINASE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS BY THE SERPIN, PROTEIN-C INHIBITOR, IN SEMEN AND BLOOD-PLASMA, Thrombosis and haemostasis, 70(6), 1993, pp. 989-994
A QUANTITATIVE ELISA FOR THE MEASUREMENT OF COMPLEXES OF PROSTATE-SPECIFIC ANTIGEN WITH PROTEIN-C INHIBITOR USING A PURIFIED STANDARD
Authors: ESPANA F SANCHEZCUENCA J VERA CD ESTELLES A GILABERT J AZNAR J
Citation: F. Espana et al., A QUANTITATIVE ELISA FOR THE MEASUREMENT OF COMPLEXES OF PROSTATE-SPECIFIC ANTIGEN WITH PROTEIN-C INHIBITOR USING A PURIFIED STANDARD, Thrombosis and haemostasis, 69(6), 1993, pp. 868-868
EVIDENCE FOR THE PHYSIOLOGICAL REGULATION OF UROKINASE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS BY THE SERPIN, PROTEIN-C INHIBITOR, IN SEMEN,URINE AND BLOOD
Authors: ESPANA F ESTELLES A HENDL SM GILABERT J AZNAR J GRIFFIN JH
Citation: F. Espana et al., EVIDENCE FOR THE PHYSIOLOGICAL REGULATION OF UROKINASE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS BY THE SERPIN, PROTEIN-C INHIBITOR, IN SEMEN,URINE AND BLOOD, Thrombosis and haemostasis, 69(6), 1993, pp. 896-896
ACTIVATION OF PROTEIN-C AND COMPLEX-FORMATION BETWEEN PROTEIN-C INHIBITOR AND TISSUE-PLASMINOGEN ACTIVATOR DURING THROMBOLYTIC THERAPY
Authors: ESPANA F VICENTE V ESTELLES A VAZQUEZ L HENDL SM SANCHEZCUENCA J AZNAR J
Citation: F. Espana et al., ACTIVATION OF PROTEIN-C AND COMPLEX-FORMATION BETWEEN PROTEIN-C INHIBITOR AND TISSUE-PLASMINOGEN ACTIVATOR DURING THROMBOLYTIC THERAPY, Thrombosis and haemostasis, 69(6), 1993, pp. 896-896
DECREASED LEVELS OF PROTEIN-C INHIBITOR DURING PREGNANCY AND PUERPERIUM
Authors: FERNANDEZ JA ESPANA F GILABERT J ESTELLES A AZNAR J
Citation: Ja. Fernandez et al., DECREASED LEVELS OF PROTEIN-C INHIBITOR DURING PREGNANCY AND PUERPERIUM, Thrombosis and haemostasis, 69(6), 1993, pp. 898-898
COMPLEX-FORMATION BETWEEN PROTEIN-C INHIBITOR AND TISSUE-PLASMINOGEN ACTIVATOR DURING THROMBOLYTIC THERAPY - EVIDENCE OF ACTIVATION OF PROTEIN-C PATHWAY
Authors: ESPANA F VICENTE V ESTELLES A VAZQUEZ L HENDL S SANCHEZCUENCA J AZNAR J
Citation: F. Espana et al., COMPLEX-FORMATION BETWEEN PROTEIN-C INHIBITOR AND TISSUE-PLASMINOGEN ACTIVATOR DURING THROMBOLYTIC THERAPY - EVIDENCE OF ACTIVATION OF PROTEIN-C PATHWAY, Fibrinolysis, 7(5), 1993, pp. 308-315
FIBRINOLYTIC CHANGES DURING ACUTE VASCULAR DAMAGE-INDUCED BY MEDITERRANEAN SPOTTED-FEVER
Authors: VICENTE V ESTELLES A MORALEDA JM ESPANA F AZNAR J
Citation: V. Vicente et al., FIBRINOLYTIC CHANGES DURING ACUTE VASCULAR DAMAGE-INDUCED BY MEDITERRANEAN SPOTTED-FEVER, Fibrinolysis, 7(5), 1993, pp. 324-329
EUGLOBULIN CLOT LYSIS INDUCED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR INSUBJECTS WITH INCREASED LEVELS AND DIFFERENT ISOFORMS OF LIPOPROTEIN (A)
Authors: AZNAR J ESTELLES A BRETO M ESPANA F
Citation: J. Aznar et al., EUGLOBULIN CLOT LYSIS INDUCED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR INSUBJECTS WITH INCREASED LEVELS AND DIFFERENT ISOFORMS OF LIPOPROTEIN (A), Thrombosis research, 72(5), 1993, pp. 459-465
EVALUATION OF 2 FUNCTIONAL ASSAYS FOR PROTEIN-C INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-3 ACTIVITY
Authors: ESPANA F HENDL S GILABERT J ESTELLES A AZNAR J
Citation: F. Espana et al., EVALUATION OF 2 FUNCTIONAL ASSAYS FOR PROTEIN-C INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-3 ACTIVITY, Thrombosis research, 70(5), 1993, pp. 375-384
A QUANTITATIVE ELISA FOR THE MEASUREMENT OF COMPLEXES OF PROSTATE-SPECIFIC ANTIGEN WITH PROTEIN-C INHIBITOR WHEN USING A PURIFIED STANDARD
Authors: ESPANA F SANCHEZCUENCA J VERA CD ESTELLES A GILABERT J
Citation: F. Espana et al., A QUANTITATIVE ELISA FOR THE MEASUREMENT OF COMPLEXES OF PROSTATE-SPECIFIC ANTIGEN WITH PROTEIN-C INHIBITOR WHEN USING A PURIFIED STANDARD, The Journal of laboratory and clinical medicine, 122(6), 1993, pp. 711-719
Risultati: 1-25 | 26-45 |